# | Title | Journal | Year | Citations |
---|
|
1 | Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report | Circulation | 2002 | 12,581 |
2 | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Hypertension | 2003 | 12,004 |
3 | Harmonizing the Metabolic Syndrome | Circulation | 2009 | 11,902 |
4 | Diagnosis and Management of the Metabolic Syndrome | Circulation | 2005 | 9,969 |
5 | Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association | Circulation | 2017 | 7,294 |
6 | Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association | Circulation | 2019 | 6,572 |
7 | Heart Disease and Stroke Statistics—2015 Update | Circulation | 2015 | 6,088 |
8 | Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association | Circulation | 2020 | 5,971 |
9 | General Cardiovascular Risk Profile for Use in Primary Care | Circulation | 2008 | 5,847 |
10 | Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines | Circulation | 2004 | 5,645 |
11 | Heart Disease and Stroke Statistics—2016 Update | Circulation | 2016 | 5,588 |
12 | Markers of Inflammation and Cardiovascular Disease | Circulation | 2003 | 5,481 |
13 | Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association | Circulation | 2018 | 5,461 |
14 | Particulate Matter Air Pollution and Cardiovascular Disease | Circulation | 2010 | 5,175 |
15 | Clinical End Points in Coronary Stent Trials | Circulation | 2007 | 5,055 |
16 | 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults | Circulation | 2014 | 4,948 |
17 | Definition of Metabolic Syndrome | Circulation | 2004 | 4,680 |
18 | Heart Disease and Stroke Statistics—2014 Update | Circulation | 2014 | 4,579 |
19 | Heart Disease and Stroke Statistics—2011 Update | Circulation | 2011 | 4,437 |
20 | Heart Disease and Stroke Statistics—2013 Update | Circulation | 2013 | 4,431 |
21 | Heart Disease and Stroke Statistics—2012 Update | Circulation | 2012 | 4,134 |
22 | Heart Disease and Stroke Statistics—2010 Update | Circulation | 2010 | 4,105 |
23 | Physical Activity and Public Health | Circulation | 2007 | 3,843 |
24 | Heart Disease and Stroke Statistics—2021 Update | Circulation | 2021 | 3,820 |
25 | Worldwide Epidemiology of Atrial Fibrillation | Circulation | 2014 | 3,712 |
26 | Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction | Circulation | 2010 | 3,710 |
27 | 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation | Circulation | 2014 | 3,560 |
28 | Standardized Bleeding Definitions for Cardiovascular Clinical Trials | Circulation | 2011 | 3,529 |
29 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Hypertension | 2018 | 3,529 |
30 | ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary | Circulation | 2004 | 3,325 |
31 | Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association | Circulation | 2023 | 3,256 |
32 | ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease | Circulation | 2006 | 3,210 |
33 | Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association | Circulation | 2022 | 3,119 |
34 | Kidney Disease as a Risk Factor for Development of Cardiovascular Disease | Circulation | 2003 | 3,117 |
35 | Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease | Circulation | 2002 | 3,081 |
36 | Contemporary Definitions and Classification of the Cardiomyopathies | Circulation | 2006 | 3,001 |
37 | Atrial Fibrillation Begets Atrial Fibrillation | Circulation | 1995 | 2,966 |
38 | ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic) | Circulation | 2006 | 2,959 |
39 | A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association | Circulation | 1975 | 2,954 |
40 | 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk | Circulation | 2014 | 2,948 |
41 | Heart Disease and Stroke Statistics—2008 Update | Circulation | 2008 | 2,886 |
42 | Coronary Plaque Disruption | Circulation | 1995 | 2,885 |
43 | 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary | Circulation | 2013 | 2,841 |
44 | Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis | Circulation | 2002 | 2,824 |
45 | Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies | Circulation | 1996 | 2,816 |
46 | Third Universal Definition of Myocardial Infarction | Circulation | 2012 | 2,795 |
47 | Universal Definition of Myocardial Infarction | Circulation | 2007 | 2,794 |
48 | Forecasting the Future of Cardiovascular Disease in the United States | Circulation | 2011 | 2,747 |
49 | 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction | Circulation | 2013 | 2,709 |
50 | Heart Disease and Stroke Statistics—2007 Update | Circulation | 2007 | 2,704 |
51 | Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness | Circulation | 2007 | 2,654 |
52 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Hypertension | 2018 | 2,621 |
53 | 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation | 2019 | 2,589 |
54 | Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation | 2017 | 2,570 |
55 | Global Disparities of Hypertension Prevalence and Control | Circulation | 2016 | 2,510 |
56 | Prevention of Infective Endocarditis | Circulation | 2007 | 2,500 |
57 | Prevalence of Hypertension in the US Adult Population | Hypertension | 1995 | 2,476 |
58 | Heart Disease and Stroke Statistics—2006 Update | Circulation | 2006 | 2,468 |
59 | Abdominal Visceral and Subcutaneous Adipose Tissue Compartments | Circulation | 2007 | 2,422 |
60 | Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss | Circulation | 2006 | 2,419 |
61 | Heart Disease and Stroke Statistics—2009 Update | Circulation | 2009 | 2,387 |
62 | Diet and Lifestyle Recommendations Revision 2006 | Circulation | 2006 | 2,379 |
63 | 2013 ACCF/AHA Guideline for the Management of Heart Failure | Circulation | 2013 | 2,379 |
64 | Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications | Circulation | 2015 | 2,375 |
65 | Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence | Circulation | 2006 | 2,340 |
66 | From Vulnerable Plaque to Vulnerable Patient | Circulation | 2003 | 2,338 |
67 | The Global Epidemic of the Metabolic Syndrome | Current Hypertension Reports | 2018 | 2,324 |
68 | A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis | Circulation | 1995 | 2,293 |
69 | Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution | Circulation | 2004 | 2,283 |
70 | 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America | Circulation | 2017 | 2,231 |
71 | Recommendations for Blood Pressure Measurement in Humans and Experimental Animals | Circulation | 2005 | 2,217 |
72 | 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults | Circulation | 2014 | 2,213 |
73 | ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult | Circulation | 2005 | 2,182 |
74 | C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events | Circulation | 2003 | 2,158 |
75 | Executive Summary: Heart Disease and Stroke Statistics—2016 Update | Circulation | 2016 | 2,148 |
76 | 2020 International Society of Hypertension Global Hypertension Practice Guidelines | Hypertension | 2020 | 2,142 |
77 | Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention | Circulation | 2003 | 2,140 |
78 | Machine Learning in Medicine | Circulation | 2015 | 2,138 |
79 | ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Circulation | 2006 | 2,131 |
80 | 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary | Circulation | 2013 | 2,111 |
81 | Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes | Circulation | 2006 | 2,108 |
82 | Vitamin D Deficiency and Risk of Cardiovascular Disease | Circulation | 2008 | 2,107 |
83 | Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Circulation | 2002 | 2,091 |
84 | Endothelial Function and Dysfunction | Circulation | 2007 | 2,090 |
85 | Fourth Universal Definition of Myocardial Infarction (2018) | Circulation | 2018 | 2,083 |
86 | Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells | Circulation | 2004 | 2,069 |
87 | 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons | Circulation | 2019 | 2,063 |
88 | Heart Disease and Stroke Statistics—2009 Update | Circulation | 2009 | 2,048 |
89 | 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults | Circulation | 2009 | 2,026 |
90 | 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease | Circulation | 2010 | 2,023 |
91 | Air Pollution and Cardiovascular Disease | Circulation | 2004 | 2,021 |
92 | Recommendations for Blood Pressure Measurement in Humans and Experimental Animals | Hypertension | 2005 | 2,011 |
93 | Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans | Circulation | 2002 | 1,988 |
94 | 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention | Circulation | 2011 | 1,972 |
95 | Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises | Circulation | 2003 | 1,963 |
96 | 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease | Circulation | 2014 | 1,945 |
97 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation | 2019 | 1,941 |
98 | Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension | Circulation | 2011 | 1,901 |
99 | Advanced Glycation End Products | Circulation | 2006 | 1,895 |
100 | Results of the Predictors of Response to CRT (PROSPECT) Trial | Circulation | 2008 | 1,893 |